NCOA6 Antikörper (AA 1954-2064)
Kurzübersicht für NCOA6 Antikörper (AA 1954-2064) (ABIN2318349)
Target
Alle NCOA6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1954-2064
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein, 250kD, Peroxisome Proliferator-activated Receptor-interacting Protein, PPAR-interacting Protein, PRIP, Thyroid Hormone Receptor-binding Protein, AIB3, KIAA0181, RAP250, TRBP)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Partial recombinant corresponding to aa1954-2064 from NCOA6 (NP_054790) with GST tag. MW of the GST tag alone is 26kD.
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- NCOA6 (Nuclear Receptor Coactivator 6 (NCOA6))
-
Andere Bezeichnung
- NCOA6
-
NCBI Accession
- NM_014071, NP_054790
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
Target
-